12. Airway Emergencies (Upper Airway Obstruction, Angioedema, Postextubation Stridor)

Quick Recap

Nests under Acute Respiratory Failure. Covers upper airway obstruction (all causes), angioedema, epiglottitis/infectious causes, and postextubation stridor/laryngeal edema. Upper airway obstruction is a CLINICAL diagnosis — do not delay securing the airway for labs, ABG, or imaging.

1. Definition

Acute compromise of the upper airway (nasopharynx through larynx/subglottis) sufficient to threaten oxygenation/ventilation. Stridor signifies at least 25% airway narrowing, and likely at least 50% narrowing if the patient is in visible distress — it is never a benign finding and should trigger an immediate, resourced response.

2. Pathophysiology

Obstruction can occur at any level from nasopharynx to subglottis, from infection, edema (allergic/angioedema/traumatic/postextubation), mass lesion, foreign body, or iatrogenic injury. Airway resistance rises exponentially (not linearly) as luminal radius decreases (Poiseuille's law: resistance is inversely proportional to radius^4), which is why a seemingly modest anatomic narrowing can produce dramatic, rapidly progressive work of breathing, and why deterioration can be abrupt rather than gradual. Complete airway obstruction is SILENT — the absence of stridor/noisy breathing in an obtunded or severely obstructed patient is an ominous sign, not reassurance.

3. Immediate Stabilization (ABCDE) — the entire protocol is essentially this section

This is a clinical diagnosis and clinical emergency. Do not delay securing the airway for labs, ABG, or imaging. History, examination, and resuscitation happen simultaneously, not sequentially.

Recognize by sound ("look, listen, feel"):

• Snoring = tongue/oropharyngeal soft tissue obstruction -> oral/nasopharyngeal airway adjunct
• Gurgling = secretions -> suction
• Stridor (typically inspiratory) = foreign body or fixed upper airway narrowing -> remove foreign body if visible/accessible, or intubate
• Wheeze = lower airway/bronchospasm -> bronchodilators (see Severe Asthma/COPD protocols)
• Silence with obvious distress or altered mental status = complete or near-complete obstruction -> intubate immediately

Airway:

• Call for experienced difficult-airway personnel early (anesthesia/ENT/surgery) — do not attempt a solo, unassisted approach to a known or suspected difficult airway
• Bring an emergency tracheostomy/cricothyroidotomy set into the room for any high-risk upper airway emergency, before it is needed
• If fiberoptic examination is performed, do so cautiously with a surgical airway backup plan and equipment already in the room — instrumentation itself can precipitate complete obstruction in a critically narrowed airway
• Cricothyroidotomy (surgical or Seldinger/percutaneous kit) is the definitive rescue when oral/nasal intubation fails or is not feasible — landmark: cricothyroid membrane between thyroid and cricoid cartilage

Breathing: 100% oxygen while assessing; be cautious of falsely reassuring SpO2 readings in carbon monoxide/inhalation injury (standard pulse oximetry cannot distinguish carboxyhemoglobin from oxyhemoglobin) — confirm with CO-oximetry blood gas if inhalation injury suspected.

Circulation: treat concurrent anaphylaxis (IM epinephrine, see below) if angioedema/allergic etiology suspected; establish IV access early.

Checklist:

4. Focused History (obtained in parallel with stabilization, not before it)

Time course (sudden = foreign body/anaphylaxis/angioedema vs subacute = infection/mass); known ACE inhibitor use (angioedema); known allergen exposure/food/medication/insect sting (anaphylaxis); hereditary angioedema family history; recent dental/oropharyngeal infection (Ludwig's angina, peritonsillar/retropharyngeal abscess); recent intubation/extubation (postextubation laryngeal edema); burn/inhalation injury exposure; foreign body aspiration witnessed or suspected (especially in a choking event); immunization status (epiglottitis risk in unvaccinated individuals); autoimmune disease (relapsing polychondritis, granulomatosis with polyangiitis can cause subglottic stenosis).

5. Examination + POCUS

Drooling, tripod positioning, muffled "hot potato" voice, trismus, visible facial/lip/tongue swelling (angioedema), neck swelling/erythema (Ludwig's angina, abscess), stridor character and phase (inspiratory = extrathoracic/upper airway; biphasic = fixed lesion; expiratory = intrathoracic), accessory muscle use, cyanosis, altered mental status (late, ominous).

POCUS/bedside imaging role is limited and secondary — this remains fundamentally a clinical diagnosis; do not send an unstable patient to imaging. Point-of-care airway ultrasound (assessing air column width) exists but is not validated at scale and should never delay definitive airway management.

6. Syndrome Identification

Upper airway obstruction syndrome — localize anatomically (nasopharynx, oropharynx, laryngopharynx) using the etiology table (Section 7) to guide both immediate airway strategy and specific therapy.

7. Etiology by Anatomic Site and Specific Therapy

8. Specific Condition Management

Epiglottitis / Infectious Laryngotracheitis

Now more common in adults than children (post-Hib vaccination era). Classic presentation: toxic-appearing adult, drooling, tripod position. Pathogens: H. influenzae, H. parainfluenzae, S. pneumoniae, S. pyogenes, S. aureus, occasionally anaerobes; diphtheria (C. diphtheriae, gray pseudomembrane on posterior pharynx) in unvaccinated individuals.

• Lateral neck X-ray may show "thumbprint sign" (swollen epiglottis) and narrowed vallecula — only if the patient is stable enough for imaging; do not send an unstable patient
• Empiric IV antibiotics: ceftriaxone 2g q24h OR ampicillin-sulbactam 1.5-3g q6h
• No strong evidence for systemic steroids, though low-to-intermediate dose methylprednisolone/dexamethasone may be reasonable in select cases
• Failure to improve on antibiotics raises concern for parapharyngeal abscess
• Diphtheria: add equine antitoxin + a macrolide antibiotic
• Involve difficult-airway-experienced personnel and have an emergency tracheostomy set in the room given high risk of complete occlusion

Angioedema

Mechanisms: ACE inhibitor-related (bradykinin-mediated), IgE-mediated allergic reaction, hereditary or acquired C1 esterase inhibitor deficiency (complement/bradykinin pathway).

• Standard therapy: stop the offending drug, antihistamines, steroids, epinephrine — note these do NOT target the bradykinin pathway and are of questionable efficacy for ACE-inhibitor or hereditary angioedema specifically, but are routinely given given diagnostic uncertainty and concern for concurrent anaphylaxis
• Hereditary/C1-esterase-inhibitor-deficiency angioedema: icatibant (selective bradykinin B2 receptor antagonist) shown to speed resolution vs steroids/antihistamines alone; other options include fresh frozen plasma (contains some C1 esterase inhibitor), purified C1 inhibitor concentrate, or ecallantide (kallikrein inhibitor)
• Do not delay intubation for pharmacologic therapy to work if there are signs of progressive airway narrowing/distress — NIV is not an appropriate strategy here given progressive anatomic narrowing

Postextubation Stridor / Laryngeal Edema

Occurs in up to 15% of extubations, usually from laryngeal edema (less commonly laryngospasm or retained secretions).

Risk factors: traumatic intubation, female sex, prolonged intubation, larger ETT size, prior difficult intubation, high cuff pressures.

Prevention: appropriately sized ETT, cuff pressure kept below 25 mmHg, confirm cuff position is not subglottic on CXR.

Pre-extubation risk assessment: cuff leak test — compares inspired vs expired tidal volume with cuff deflated after thorough suctioning; high negative predictive value (a positive leak reassures against edema) though sensitivity/specificity vary by cutoff used. In high-risk patients without an adequate leak: at least 2 doses of prophylactic corticosteroids, first dose 4-12+ hours before extubation, reduces postextubation laryngeal edema risk.

High-risk extubation strategy: consider leaving an airway exchange catheter in place post-extubation to allow rapid re-intubation if needed (attention to insertion depth to avoid pneumothorax).

Treatment of established postextubation stridor: nebulized racemic epinephrine (local vasoconstriction); short-course (48h) IV corticosteroids commonly used despite lack of RCT support; heliox may reduce work of breathing and buy time for steroids to act in patients NOT in distress; any patient in respiratory distress should be reintubated — do not delay for pharmacologic measures to work.

9. Investigations

Generally secondary to immediate airway management in unstable patients. In stable/improving patients: lateral neck X-ray (epiglottitis "thumbprint sign"), CT neck/soft tissue (abscess characterization, mass lesion), CO-oximetry ABG if inhalation injury/CO poisoning suspected, blood cultures if infectious etiology, allergy/complement workup (C4, C1 esterase inhibitor level/function) for recurrent angioedema without clear ACE-inhibitor/allergic trigger.

10. Consultation Matrix

11. Monitoring Framework

Continuous SpO2/work-of-breathing assessment; frequent reassessment of stridor severity and voice change; low threshold to re-examine/re-image if any deterioration; post-airway-securing monitoring for the underlying cause's response to treatment (antibiotics, steroids, etc.).

12. Complications

Complete airway obstruction/cardiorespiratory arrest (the central risk this entire protocol exists to prevent), failed intubation requiring surgical airway, aspiration, pneumothorax from airway exchange catheter misplacement, recurrent angioedema episodes, laryngeal/subglottic stenosis from prolonged/traumatic intubation. Prevention: early escalation and resourcing, appropriate ETT sizing/cuff pressure management, cuff leak test and prophylactic steroids in high-risk extubations. Rescue: cricothyroidotomy/surgical airway, reintubation for postextubation stridor with distress.

13. Escalation & De-escalation

Escalate: any progression in stridor severity, voice change, drooling, or distress -> secure airway now, do not wait for confirmatory testing.

De-escalate: underlying cause treated/resolving (infection responding to antibiotics, angioedema resolved, postextubation edema settled) -> extubate/decannulate per standard criteria once airway patency reconfirmed (e.g., repeat cuff leak test or direct visualization).

14. Documentation & Medicolegal Checklist

15. Key Guidelines / Reference Reviews

Eskander A, de Almeida JR, Irish JC. Acute upper airway obstruction. N Engl J Med. 2019;20:1940-1949 (comprehensive review). Heidegger T. Management of the difficult airway. N Engl J Med. 2021;19:1836-1847 (difficult airway definitions, predictors, management).

16. Landmark Evidence

Bas M, Greve J, Stelter K, et al. A randomized trial of icatibant in ACE-inhibitor-induced angioedema. N Engl J Med. 2015;372:418-425 — icatibant produced faster resolution than steroids/antihistamines alone, though standard therapy remains widely used given diagnostic uncertainty.

17. Controversies

Role of standard angioedema therapy (steroids/antihistamines/epinephrine) in ACE-inhibitor-mediated and hereditary angioedema is limited by mechanism (bradykinin, not histamine/IgE-mediated) yet remains routine practice due to diagnostic uncertainty at presentation and anaphylaxis overlap concern. Evidence for prophylactic/treatment corticosteroids in postextubation laryngeal edema and epiglottitis is weaker than commonly assumed (not RCT-validated in either case) despite near-universal use. Optimal cuff leak test cutoff value for predicting postextubation stridor risk varies across studies without a single validated threshold.

18. References

1. Patel TM, Kollef MH. Upper Airway Obstruction. Washington Manual of Critical Care, 4th ed, 2025 (Ch. 10).
2. Postextubation stridor / NIV chapter content. Washington Manual of Critical Care, 4th ed, 2025 (Ch. 19).
3. Eskander A, de Almeida JR, Irish JC. Acute upper airway obstruction. N Engl J Med. 2019;381(20):1940-1949.
4. Heidegger T. Management of the difficult airway. N Engl J Med. 2021;384(19):1836-1847.
5. Bas M, Greve J, Stelter K, et al. A randomized trial of icatibant in ACE-inhibitor-induced angioedema. N Engl J Med. 2015;372:418-425.
6. Sharma J, Tiwari A. Initial Assessment and Resuscitation. ICU Protocols: A Step-wise Approach, 2nd ed. Springer; 2020 (Ch. 23).